System for the in vivo delivery and expression of heterologous genes in the bone marrow
Patent Number: 6583121
Date of First Priority Issue: Wednesday February 19th, 1997
Date Issued: Tuesday June 24th, 2003
Assignee: University of North Carolina at Chapel Hill (Chapel Hill, NC)
Inventors: Johnston, Robert E. (Chapel Hill, NC); Davis, Nancy L. (Chapel Hill, NC); Simpson, Dennis A. (Chapel Hill, NC)
From Class: Use
Comments: No comments
Gene therapy would greatly benefit from the ability to use stem cells as vectors. This patent addresses the problem of transfecting stem cells through the use of alpha viruses. Some clinical trials are already underway using alpha viruses.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.